These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 26527046)

  • 1. Long-Term Stroke Risk Due to Partial White-Coat or Masked Hypertension Based on Home and Ambulatory Blood Pressure Measurements: The Ohasama Study.
    Satoh M; Asayama K; Kikuya M; Inoue R; Metoki H; Hosaka M; Tsubota-Utsugi M; Obara T; Ishiguro A; Murakami K; Matsuda A; Yasui D; Murakami T; Mano N; Imai Y; Ohkubo T
    Hypertension; 2016 Jan; 67(1):48-55. PubMed ID: 26527046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White-coat and masked hypertension are associated with carotid atherosclerosis in a general population: the Hisayama study.
    Fukuhara M; Arima H; Ninomiya T; Hata J; Hirakawa Y; Doi Y; Yonemoto K; Mukai N; Nagata M; Ikeda F; Matsumura K; Kitazono T; Kiyohara Y
    Stroke; 2013 Jun; 44(6):1512-7. PubMed ID: 23640825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for classifying patients based on office, home, and ambulatory blood pressure measurement.
    Zhang L; Li Y; Wei FF; Thijs L; Kang YY; Wang S; Xu TY; Wang JG; Staessen JA
    Hypertension; 2015 Jun; 65(6):1258-65. PubMed ID: 25870194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study.
    Ohkubo T; Kikuya M; Metoki H; Asayama K; Obara T; Hashimoto J; Totsune K; Hoshi H; Satoh H; Imai Y
    J Am Coll Cardiol; 2005 Aug; 46(3):508-15. PubMed ID: 16053966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of white-coat and masked hypertension: International Database of HOme blood pressure in relation to Cardiovascular Outcome.
    Stergiou GS; Asayama K; Thijs L; Kollias A; Niiranen TJ; Hozawa A; Boggia J; Johansson JK; Ohkubo T; Tsuji I; Jula AM; Imai Y; Staessen JA;
    Hypertension; 2014 Apr; 63(4):675-82. PubMed ID: 24420553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term risk of sustained hypertension in white-coat or masked hypertension.
    Mancia G; Bombelli M; Facchetti R; Madotto F; Quarti-Trevano F; Polo Friz H; Grassi G; Sega R
    Hypertension; 2009 Aug; 54(2):226-32. PubMed ID: 19564548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similar levels of low-grade inflammation and arterial stiffness in masked and white-coat hypertension: comparisons with sustained hypertension and normotension.
    Andrikou I; Tsioufis C; Dimitriadis K; Syrseloudis D; Valenti P; Almiroudi M; Lioni L; Tousoulis D; Stefanadis C
    Blood Press Monit; 2011 Oct; 16(5):218-23. PubMed ID: 21914984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term cardiovascular risk of white-coat hypertension with normal night-time blood pressure values.
    Faria J; Mesquita-Bastos J; Bertoquini S; Silva J; Barbosa L; Polónia J
    Blood Press Monit; 2019 Apr; 24(2):59-66. PubMed ID: 30856622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White-coat and masked hypertension as risk factors for progression to sustained hypertension: the Finn-Home study.
    Sivén SS; Niiranen TJ; Kantola IM; Jula AM
    J Hypertens; 2016 Jan; 34(1):54-60. PubMed ID: 26630213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term prognostic value of white coat hypertension: an insight from diagnostic use of both ambulatory and home blood pressure measurements.
    Mancia G; Bombelli M; Brambilla G; Facchetti R; Sega R; Toso E; Grassi G
    Hypertension; 2013 Jul; 62(1):168-74. PubMed ID: 23716584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of masked and white-coat hypertension in the general population: the Finn-Home Study.
    Hänninen MR; Niiranen TJ; Puukka PJ; Johansson J; Jula AM
    J Hypertens; 2012 Apr; 30(4):705-12. PubMed ID: 22278146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of assessing masked and white-coat hypertension by ambulatory blood pressure monitoring for determining prevalent risk of chronic kidney disease: the Ohasama study.
    Kanno A; Metoki H; Kikuya M; Terawaki H; Hara A; Hashimoto T; Asayama K; Inoue R; Shishido Y; Nakayama M; Totsune K; Ohkubo T; Imai Y
    Hypertens Res; 2010 Nov; 33(11):1192-8. PubMed ID: 20703228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure variability in elderly persons with white-coat and masked hypertension compared to those with normotension and sustained hypertension.
    Cacciolati C; Tzourio C; Hanon O
    Am J Hypertens; 2013 Mar; 26(3):367-72. PubMed ID: 23382487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Masked hypertension, rather than white-coat hypertension, has a prognostic role in patients with non-dialysis chronic kidney disease.
    Wang C; Zhang J; Li Y; Ma X; Ye Z; Peng H; Lou T
    Int J Cardiol; 2017 Mar; 230():33-39. PubMed ID: 28034462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, determinants, and clinical significance of masked hypertension and white-coat hypertension in patients with chronic kidney disease.
    Tang H; Gong WY; Zhang QZ; Zhang J; Ye ZC; Peng H; Wang C; Lou T
    Nephrology (Carlton); 2016 Oct; 21(10):841-50. PubMed ID: 26566951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Cardiovascular Outcomes With Masked Hypertension Defined by Home Blood Pressure Monitoring in a Japanese General Practice Population.
    Fujiwara T; Yano Y; Hoshide S; Kanegae H; Kario K
    JAMA Cardiol; 2018 Jul; 3(7):583-590. PubMed ID: 29800067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)].
    Hermida RC; Smolensky MH; Ayala DE; Portaluppi F; Crespo JJ; Fabbian F; Haus E; Manfredini R; Mojón A; Moyá A; Piñeiro L; Ríos MT; Otero A; Balan H; Fernández JR
    Clin Investig Arterioscler; 2013; 25(2):74-82. PubMed ID: 23849214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of dysregulation of glucose metabolism with white-coat hypertension: the Ohasama study.
    Hosaka M; Mimura A; Asayama K; Ohkubo T; Hayashi K; Kikuya M; Sato M; Hashimoto T; Kanno A; Hara A; Obara T; Metoki H; Inoue R; Hoshi H; Satoh H; Oka Y; Imai Y
    Hypertens Res; 2010 Sep; 33(9):937-43. PubMed ID: 20631718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension].
    Kario K; Shimada K; Schwartz JE; Matsuo T; Hoshide S; Pickering TG
    J Cardiol; 2002 Jan; 39(1):52-4. PubMed ID: 11828799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep-time blood pressure and the prognostic value of isolated-office and masked hypertension.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Am J Hypertens; 2012 Mar; 25(3):297-305. PubMed ID: 22089106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.